Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Detailed Quotes

PHAR Pharming Group

Watchlist
11.760
+0.010+0.09%
Close 11/25 13:00 ET
11.7600.0000.00%
Post Mkt Price 11/25 13:00 ET
High
12.540
Open
12.000
Turnover
97.62K
Low
11.500
Pre Close
11.750
Volume
8.06K
Market Cap
767.24M
P/E(TTM)
26.13
52wk High
12.979
Shares
65.24M
P/E(Static)
51.13
52wk Low
6.100
Float Cap
741.30M
Bid/Ask %
50.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
5.02
Historical Low
6.100
Dividend TTM
--
Div Yield TTM
--
P/B
3.83
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
8.85%
Avg Price
12.114
Lot Size
1
Float Cap
741.30M
Bid/Ask %
50.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
5.02
Historical Low
6.100
Dividend TTM
--
P/B
3.83
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
8.85%
Avg Price
12.114
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
CEO: Dr. Sijmen (Simon) de Vries, M.D.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist